Comparable outcomes in early hepatocellular carcinomas treated with trans-arterial chemoembolization and radiofrequency ablation

HIGHLIGHTS

  • who: Tay Wei Rong Benjamin and collaborators from the Division of Gastroenterology and Hepatology, National University Health System have published the article: Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation, in the Journal: Biomedicines 2022, 10, 2361. of 31/Dec/2014
  • what: The authors aimed to compare the clinical outcomes for TACE and RFA in early HCC. The study shows that treatment with either TACE or RFA for tumors less than 3 cm did not result in a significant difference in overall survival. All the patients in the study . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?